title: [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
authors.forename: F Z
authors.initials: FZ
authors.lastname: Agharbi
authors.forename: M
authors.initials: M
authors.lastname: Meziane
authors.forename: H
authors.initials: H
authors.lastname: Benhemmne
authors.forename: K
authors.initials: K
authors.lastname: Daoudi
authors.forename: O
authors.initials: O
authors.lastname: Elmesbahi
authors.forename: O
authors.initials: O
authors.lastname: Mikou
authors.forename: F Z
authors.initials: FZ
authors.lastname: Mernissi
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005500:Follow-Up Studies; D060831:Hand-Foot Syndrome / Q000175:diagnosis*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D012075:Remission, Spontaneous
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil